Active substanceTaurineTaurine
Similar drugsTo uncover
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Igrele®
    drops d / eye 
    KVADRAT-S, LLC     Russia
  • CardioActiv® Taurine
    pills inwards 
    EVALAR, CJSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    UPDATE OF PFC, CJSC     Russia
  • Taurine
    drops d / eye 
    VIFITEH, CJSC     Russia
  • Taurine
    solution
    DALHIMFARM, OJSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    Firm VIPS-MED, LLC     Russia
  • Taurine
    films d / eye 
    Progress RCC, JSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    Company DEKO, LLC     Russia
  • Taurine
    drops d / eye 
  • Taurin-Akos
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Taurin-DIA
    drops d / eye 
  • Taurin-SOLOFARM
    drops d / eye 
    GROTEKS, LLC     Russia
  • Taufon
    drops d / eye 
  • Dosage form: & nbspeye film
    Composition:

    Composition: (per film)

    Taurine-3 mg.

    Excipients: Macrogol (polyethylene oxide) 4000 - 1.6 mg, potassium dihydro orthophosphate - 0.5 mg, a polymer biosoluble for drug films - a sufficient amount to produce a film weighing 16 mg.

    Description:

    Polymer plates oval in shape with blunted edges, white or with a yellowish hue, with dimensions (9.0 x 4.5 x 0.35) mm

    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    S.01.X.A   Other drugs for the treatment of eye diseases

    C.01.E.B   Other drugs for the treatment of heart disease

    Pharmacodynamics:

    Taurine stimulates reparative processes in diseases of a dystrophic nature and in violation of metabolism in the tissues of the eye. Normalizes the function of cell membranes, promotes the activation of metabolic and energy processes and the preservation of the electrolyte composition of the plasma due to the accumulation of potassium and calcium ions, improves the conditions for the passage of the nerve impulse.

    Pharmacokinetics:

    The eye film when applied to the conjunctival cavity, moistened with tear fluid, passes into an elastic (soft) state and is retained in the lower conjunctival arch until completely dissolved. The release of the active substance begins immediately after contact of the film with the conjunctiva. In the conjunctival cavity is almost not absorbed, systemic absorption is low. The time of complete dissolution is 20 - 60 minutes, the prolonging action is within 24 - 36 hours.

    Indications:They are used as a stimulant for reparative processes in the tissues of corneal dystrophy, as well as as a means of stimulating the recovery processes in corneal injuries as part of complex therapy.
    Contraindications:

    Individual hypersensitivity to taurine, a tendency to drug allergy, the presence of a history of recurrent corneal erosions, pregnancy and lactation, children under 18 years of age.

    Dosing and Administration:

    Locally.

    Eye films are laid behind the lower eyelid. The film is extracted with a clean ophthalmic tweezers from the outline of the cell pack and, pulling the lower eyelid, lay it in the formed space between the eyelid and the eyeball. Then the eyelids release and hold the eye in a calm (immobile) state for 30-60 seconds to wet the film and transfer it to an elastic (soft) state.

    For the treatment of dystrophy, the cornea is applied once a day or two days, for the course of treatment 10-15 films.

    In case of trauma, the cornea is applied once a day. The course of treatment is 10 days.

    Side effects:

    Sensation of foreign body in the eye (if it does not pass within 3-5 minutes - the film must be removed). Minor hyperemia of the conjunctiva.Allergic reaction.

    Overdose:Cases of overdose are not described.
    Special instructions:When applying Taufon, the phenomena of intolerance are possible in cases of application of films, especially in the shallow lower conjunctival arch.
    Form release / dosage:

    Eye membranes 3 mg.

    10 pieces per contour cell pack. 1 or 3 contour packs along with the instruction for use are placed in a cardboard box. Packs, together with instructions for use, are placed in carton boxes.

    Packaging:(10) - packings, cellular, outline (1) - packs, cardboard
    (10) - packings, cellular, outline (3) - packs, cardboard
    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-010454/09
    Date of registration:22.12.2009
    The owner of the registration certificate:Progress RCC, JSCProgress RCC, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp05.09.2015
    Illustrated instructions
      Instructions
      Up